Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201308060 Principal Investigator: Uy, Geoffrey
Title: An open label, Phase I/IIa, dose escalation trial to investigate the maximum tolerated dose, safety, pharmacokinetics, and efficacy of volasertib in combination with decitabine in patients >65 years with acute myeloid leukemia
Phase: I/II Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study will investigate how well a new drug called volasertib (BI 6727) works when used in combination with decitabine (Dacogen®) in adult patients with AML. The study will also investigate the possible side effects of the drug.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)